# Cluster4-39 Analysis

## Proteins: 

CNNM1, DUSP16, MAPKAPK5, RPS6KA4, RPS6KA5

### Nuclear Serine/Threonine Kinase Signaling Complex

**Summary**

The human protein system under analysis consists of five proteins: CNNM1, DUSP16, MAPKAPK5, RPS6KA4, and RPS6KA5. These proteins are involved in various cellular processes, including protein binding, kinase activity, and signal transduction. The majority of these proteins are localized in the nucleus and nucleoplasm, with some also found in the cytoplasm and cytosol. The system appears to be involved in several biological processes, such as protein phosphorylation, chromatin remodeling, transcription regulation, and inflammatory response. Based on the cellular location and function, we propose the name "Nuclear Serine/Threonine Kinase Signaling Complex" for this system.

The proteins in this system are involved in protein serine/threonine kinase activity, which is essential for various cellular processes, including cell growth, differentiation, and apoptosis (1). MAPKAPK5, RPS6KA4, and RPS6KA5 are known to have this activity, and they also bind ATP, which is necessary for their kinase function (2). DUSP16 and MAPKAPK5 are involved in mitogen-activated protein kinase (MAPK) binding, which is crucial for signal transduction in the cell (3).

The system is also involved in chromatin remodeling and transcription regulation, with RPS6KA4 and RPS6KA5 playing a role in histone H3S10 and H3S28 kinase activity, as well as CREB and NF-kappaB transcription factor activity (4). These proteins are also involved in the negative regulation of cytokine production and the interleukin-1-mediated signaling pathway, which are essential for the inflammatory response (5).

**References**

1. Cohen, P. (2002). The role of protein phosphorylation in human health and disease. European Journal of Biochemistry, 269(22), 5361-5375.

2. Manning, G., Whyte, D. B., Martinez, R., Hunter, T., & Sudarsanam, S. (2002). The protein kinase complement of the human genome. Science, 298(5600), 1912-1934.

3. Kyriakis, J. M., & Avruch, J. (2012). Mammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year update. Physiological Reviews, 92(2), 689-737.

4. Sapkota, G. P., Cummings, L., Newell, F. S., Armstrong, C., Bain, J., Frodin, M., ... & Cohen, P. (2007). BI-D1870 is a specific inhibitor of the p90 RSK (ribosomal S6 kinase) isoforms in vitro and in vivo. Biochemical Journal, 401(1), 29-38.

5. Dinarello, C. A. (2009). Immunological and inflammatory functions of the interleukin-1 family. Annual Review of Immunology, 27, 519-550.

## Gene Feature Summary: 

| Feature | Number of Genes | Genes |
| --- | --- | --- |
| protein binding | 5 | CNNM1, DUSP16, MAPKAPK5, RPS6KA4, RPS6KA5 |
| nucleus | 4 | DUSP16, MAPKAPK5, RPS6KA4, RPS6KA5 |
| nucleoplasm | 4 | DUSP16, MAPKAPK5, RPS6KA4, RPS6KA5 |
| cytoplasm | 4 | DUSP16, MAPKAPK5, RPS6KA4, RPS6KA5 |
| cytosol | 3 | DUSP16, MAPKAPK5, RPS6KA4 |
| protein serine/threonine kinase activity | 3 | MAPKAPK5, RPS6KA4, RPS6KA5 |
| ATP binding | 3 | MAPKAPK5, RPS6KA4, RPS6KA5 |
| protein serine kinase activity | 3 | MAPKAPK5, RPS6KA4, RPS6KA5 |
| mitogen-activated protein kinase binding | 2 | DUSP16, MAPKAPK5 |
| magnesium ion binding | 2 | RPS6KA4, RPS6KA5 |
| histone H3S10 kinase activity | 2 | RPS6KA4, RPS6KA5 |
| histone H3S28 kinase activity | 2 | RPS6KA4, RPS6KA5 |
| negative regulation of cytokine production | 2 | RPS6KA4, RPS6KA5 |
| chromatin remodeling | 2 | RPS6KA4, RPS6KA5 |
|  DNA-templated transcription | 2 | RPS6KA4, RPS6KA5 |
| protein phosphorylation | 2 | RPS6KA4, RPS6KA5 |
| inflammatory response | 2 | RPS6KA4, RPS6KA5 |
|  CREB transcription factor activity | 2 | RPS6KA4, RPS6KA5 |
| intracellular signal transduction | 2 | RPS6KA4, RPS6KA5 |
| post-translational protein modification | 2 | RPS6KA4, RPS6KA5 |
|  transcription by RNA polymerase II | 2 | RPS6KA4, RPS6KA5 |
|  NF-kappaB transcription factor activity | 2 | RPS6KA4, RPS6KA5 |
| interleukin-1-mediated signaling pathway | 2 | RPS6KA4, RPS6KA5 |

